title: Impact of heparin-induced thrombocytopenia on acute coronary artery thrombosis in patients undergoing PCI.
authors.forename: T
authors.initials: T
authors.lastname: Maeda
authors.forename: T
authors.initials: T
authors.lastname: Noguchi
authors.forename: S
authors.initials: S
authors.lastname: Saito
authors.forename: R
authors.initials: R
authors.lastname: Yoshioka
authors.forename: E
authors.initials: E
authors.lastname: Horibe
authors.forename: S
authors.initials: S
authors.lastname: Miyanaga
authors.forename: S
authors.initials: S
authors.lastname: Seguchi
authors.forename: Y
authors.initials: Y
authors.lastname: Kanaumi
authors.forename: T
authors.initials: T
authors.lastname: Kawai
authors.forename: H
authors.initials: H
authors.lastname: Okazaki
authors.affiliation: Shigeki Miyata, MD, PhD, Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita-city, Osaka 565-8565, Japan, Tel.: +81 6 6833 5012 Ext. 2294, Fax: +81 6 6872 8175, E-mail: smiyata@hsp.ncvc.go.jp.
authors.forename: S
authors.initials: S
authors.lastname: Miyata
mesh_terms: D000208:Acute Disease; D003328:Coronary Thrombosis / Q000209:etiology / Q000517:prevention & control*; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007564:Japan; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality / Q000601:surgery*; D062645:Percutaneous Coronary Intervention; D015539:Platelet Activation / Q000187:drug effects; D010978:Platelet Factor 4 / Q000276:immunology / Q000378:metabolism; D011183:Postoperative Complications / Q000517:prevention & control*; D012189:Retrospective Studies; D016019:Survival Analysis; D013921:Thrombocytopenia / Q000139:chemically induced / Q000175:diagnosis*; D016896:Treatment Outcome
chemical_list: D007074:Immunoglobulin G; D010978:Platelet Factor 4; D006493:Heparin